跳至主要内容
临床试验/DRKS00004587
DRKS00004587已完成4 期

Epidermal Nerve Fibre Density Reduction as a Function of Application Time of topical high-dose and low-dose Capsaicin - ENFDCAP

niversitätsklinik Wien0 个研究点目标入组 12 人开始时间: 2012年12月5日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • healthy male and female volunteers 18 > age < 80
  • informed consent
  • dermal and neurological integrity of the foresides of the thighs
  • female volunteers - not pregnant or breast feeding

排除标准

  • anamnestic injury or surgery of the thighs
  • Nerved damage (Nervus femoralis or lumbal nerval roots 2-4)
  • lack or different information by testing of sensitivity disturbance, impaired experience of pain and temperature in the area of the fore of the thighs
  • prior use of Qutenza or other topical capsaicin preparations in the area of the firesides of the thighs in between 3 months prior to the start of the investigation
  • known hypersensitivity to capsaicin
  • known hypersensitivity to local anesthetic ointment Emla- Creme® (Lidocaine, Prilocaine, Macrogolglycerolhydroxystearat, Carbomer)
  • known hypersensitivity to Ultrasicc® (Petrolatum, Cera Microcristallina, Stearylalkohol, Macrogolstearat 2000, Polyacrylacid, Natriumedetat, Propyl-4-hydroxybenzoat) as carrier substance of the Capsaicin 0,05% Creme
  • known hypersensitivity to Qutenza® (Capsaicin, silicone-adhesives, Diethylenglycolmonoethylether, Dimeticone, Ethylcellulose) cleansing gel (Macrogol 300, Carbomer 1382, Natriumedetat, Butylhydroxyanisol)
  • known hypersensitivity to paracetamol
  • unstable hypertension, current cardiovascular event, methaemoglobinaemia, G6PDH-Insufficiency, hepatic insufficiency, use of antiarrhythmics, known alcohol or drug abuse
  • participation in another trial
  • Pregnancy or breast feeding

研究者

发起方
niversitätsklinik Wien

相似试验